$UPYY Balance Sheet | Understand Stock

$UPYY

$0.90 -$0.10 (10.0%) Close

$UPYY Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In USD, except per-share amounts

	Q2 FY2027 As of Aug 31, 2026	Q1 FY2027 As of May 31, 2026	Q4 FY2026 As of Feb 28, 2026	Q3 FY2026 As of Nov 30, 2025	Q2 FY2026 As of Aug 31, 2025	Q1 FY2026 As of May 31, 2025	Q4 FY2025 As of Feb 28, 2025	Q3 FY2025 As of Nov 30, 2024	Q2 FY2025 As of Aug 31, 2024	Q1 FY2025 As of May 31, 2024	Q4 FY2024 As of Feb 29, 2024	Q3 FY2024 As of Nov 30, 2023	Q2 FY2024 As of Aug 31, 2023	Q1 FY2024 As of May 31, 2023	Q4 FY2023 As of Feb 28, 2023	Q3 FY2023 As of Nov 30, 2022	Q2 FY2023 As of Aug 31, 2022	Q1 FY2023 As of May 31, 2022	Q4 FY2022 As of Feb 28, 2022	Q3 FY2022 As of Nov 30, 2021
Assets
Current Assets
Cash and cash equivalents
Accounts receivable, net of allowance
Prepaid expenses and other current assets
Total Current Assets
Equity Method Investment (Note 3)
Property and Equipment, Net (Note 4)
Right-of-use Assets, Net (Note 5)
Deposit (Note 12)
Total Assets

LIABILITIES AND STOCKHOLDERS' DEFICIT
Current Liabilities
Accounts payable and accrued liabilities
Due to related parties (Note 6)
Taxes payable
Current Portion of Notes Payable – Related Party (Note 6)
Current portion of lease liabilities (Note 8)
Current portion of notes payable (Note 7)
Current portion of notes payable in default (Note 7)
Notes payable – Related parties (Note 6)
Current portion of notes payable – Related parties in default (Note 5)
Total Current Liabilities

Non-Current Liabilities
Notes Payable – Related Party (Note 6)
Lease liabilities (Note 8)
Notes payable (Note 7)
Notes payable – Related parties (Note 6)

Total Liabilities
Stockholders' Deficit
Preferred Stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding
Common Stock, $0.001 par value, 100,000,000 shares authorized; 18,665,211 and 17,595,211 shares issued and outstanding, respectively
Common Stock Issuable
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total UPAY Stockholders' Deficit
Noncontrolling Interest
Total Stockholders' Deficit
Total Liabilities and Stockholders' Deficit

Comments